Marshall Wace LLP Acquires Shares of 281,136 Definitive Healthcare Corp. (NASDAQ:DH)

Marshall Wace LLP bought a new stake in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 281,136 shares of the company's stock, valued at approximately $1,535,000. Marshall Wace LLP owned about 0.24% of Definitive Healthcare as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Susquehanna Fundamental Investments LLC acquired a new stake in Definitive Healthcare during the first quarter valued at $120,000. Vanguard Group Inc. grew its stake in shares of Definitive Healthcare by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 4,535,377 shares of the company's stock valued at $36,600,000 after buying an additional 67,068 shares in the last quarter. Boston Partners acquired a new position in Definitive Healthcare in the first quarter worth approximately $550,000. Swiss National Bank raised its position in Definitive Healthcare by 2.9% during the first quarter. Swiss National Bank now owns 103,300 shares of the company's stock valued at $834,000 after acquiring an additional 2,900 shares in the last quarter. Finally, Comerica Bank lifted its stake in Definitive Healthcare by 9.3% in the first quarter. Comerica Bank now owns 436,831 shares of the company's stock valued at $3,525,000 after acquiring an additional 37,044 shares during the last quarter. Institutional investors and hedge funds own 98.67% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Definitive Healthcare from $7.00 to $5.00 and set a "hold" rating on the stock in a research note on Friday, August 9th. JPMorgan Chase & Co. lowered Definitive Healthcare from a "neutral" rating to an "underweight" rating and cut their target price for the company from $7.00 to $5.00 in a report on Wednesday, July 31st. Barclays decreased their price target on Definitive Healthcare from $6.00 to $4.00 and set an "equal weight" rating for the company in a research note on Wednesday, August 7th. Morgan Stanley cut their price objective on Definitive Healthcare from $9.00 to $5.00 and set an "equal weight" rating on the stock in a research note on Tuesday, August 6th. Finally, Stifel Nicolaus decreased their target price on Definitive Healthcare from $9.50 to $7.50 and set a "buy" rating for the company in a research report on Wednesday, July 31st. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $5.81.

Definitive Healthcare Trading Down 0.2 %

Shares of DH opened at $4.34 on Friday. The stock's 50-day moving average price is $4.32 and its 200 day moving average price is $5.59. The company has a quick ratio of 2.40, a current ratio of 2.40 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $511.84 million, a price-to-earnings ratio of -2.48, a P/E/G ratio of 6.49 and a beta of 1.33. Definitive Healthcare Corp. has a 12-month low of $3.19 and a 12-month high of $10.62.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last issued its earnings results on Monday, August 5th. The company reported $0.09 EPS for the quarter, meeting analysts' consensus estimates of $0.09. Definitive Healthcare had a positive return on equity of 0.98% and a negative net margin of 156.65%. The business had revenue of $63.70 million during the quarter, compared to analyst estimates of $63.19 million. During the same period in the prior year, the company posted $0.08 earnings per share. Definitive Healthcare's revenue was up 4.4% on a year-over-year basis. As a group, research analysts predict that Definitive Healthcare Corp. will post 0.07 earnings per share for the current year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.